Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond

QR Code

Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond

Issue. Since the mid-1990s, there have been calls to make naloxone, a prescription-only medicine in many countries, available to heroin and other opioid users and their peers and family members to prevent overdose deaths. Context. In Australia there were calls for a trial of peer naloxone in 2000, y...

Full description

Bibliographic Details
Main Authors:	Lenton, Simon, Dietze, P., Olsen, A., Wiggins, N., McDonald, D., Fowler, C.
Format:	Journal Article
Published:	Wiley-Blackwell Publishing Ltd. 2014
Subjects:	peer naloxone opioid overdose Australia policy
Online Access:	http://hdl.handle.net/20.500.11937/42344

Similar Items

Commentary on Williams et al. (2014): Family matters—new resources for managing opioid overdose with take-home naloxone
by: Tait, Robert, et al.
Published: (2014)

Naloxone for administration by peers in cases of heroin overdose
by: Lenton, Simon, et al.
Published: (2009)

Editorial: Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia
by: Lenton, Simon, et al.
Published: (2009)

Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?
by: Lenton, Simon, et al.
Published: (2000)

A Prospective Study of Non-Fatal Heroin Overdose
by: Fatovich, D., et al.
Published: (2008)

Developing a single-session strategy for the implementation of take-home naloxone by community pharmacists using COM-B and design-thinking
by: Moullin, Joanna, et al.
Published: (2023)

Editorial: A trial of naloxone for peer administration has merit, but will the lawyers let it happen?
by: Lenton, Simon, et al.
Published: (2000)

Australia reschedules naloxone for opioid overdose
by: Lenton, Simon, et al.
Published: (2016)

Evaluation of opioid-related deaths associated with opioid utilisation and the impacts of tramadol classification as a Schedule III Controlled Drug in the United Kingdom
by: Chen, Teng-Chou
Published: (2019)

EXPANDING THE AVAILABILITY OF NALOXONE IN AUSTRALIA: REVIEWING THE FIRST YEAR
by: Olsen, A., et al.
Published: (2013)

Medications used in overdose and how they are acquired – an investigation of cases attending an inner Melbourne emergency department
by: Buykx, P., et al.
Published: (2010)

WIDER AVAILABILITY OF NALOXONE TO PREVENT OPIOID OVERDOSE FATALITIES - INTERNATIONAL EVIDENCE UNDERPINNING AUSTRALIAN DEVELOPMENTS
by: Lenton, Simon
Published: (2013)

Investigations Into Solvate forms of Naloxone using Solid-State NMR and Simulations
by: Mitchell-Thurston, Charles
Published: (2024)

The relationship between non-fatal overdose of pharmaceutical medications, suicidality and depression
by: Buykx, Penelope
Published: (2007)

Evaluation of the 'Implementing Expanded Naloxone Availability in the ACT (I-ENAACT) Program' 2011-2014
by: Olsen, A., et al.
Published: (2015)

Nonfatal overdose from alcohol and/or drugs among a sample of recreational drug users
by: Martin, G., et al.
Published: (2014)

Role of Community Pharmacists in Optimizing Opioid Therapy for Chronic Non-malignant Pain Patients in Pakistan
by: Iqbal, Ayesha
Published: (2023)

Design and synthesis of fluorescent opioids for bioimaging
by: Lam, Raymond
Published: (2018)

Explainer: what is naloxone and how can it help save drug users who overdose?
by: Lenton, Simon, et al.
Published: (2015)

Morbidity associated with heroin overdose presentations to an emergency department: A 10-year record linkage study
by: Fatovich, D., et al.
Published: (2010)

Potential impacts on the incidence of fatal heroin-related overdose in Western Australia: a time-series analysis
by: Hargreaves, K., et al.
Published: (2002)

The Hidden Danger: Unintended Overdose With Prescription Medication Due to Non-Medical Use
by: Guggisberg, Marika
Published: (2013)

Investigating the association between opioid analgesics and the risk of bone fracture
by: Peach, Emily J.
Published: (2020)

Prescribed opioid use is associated with adverse cardiovascular outcomes in community-dwelling older persons
by: Liew, S.M., et al.
Published: (2022)

New chemistry to support the search for more effective opioids
by: Yang, Ruoyan
Published: (2020)

Grievable lives? Death by opioid overdose in Australian newspaper coverage
by: Fraser, Suzanne, et al.
Published: (2018)

An exploration of strong opioid utilisation in non-cancer pain patients in UK primary care, 2000-2010
by: Adan Hag Hersi, Muna
Published: (2018)

Is tapentadol different from classical opioids?: a review of the evidence
by: Langford, Richard M., et al.
Published: (2016)

EVIDENCE FOR TAKE-HOME NALOXONE PROGRAMS: A BRADFORD HILL ANALYSIS
by: Olsen, A., et al.
Published: (2014)

Characteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone
by: Bartu, Anne, et al.
Published: (2002)

Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia
by: Dietze, P., et al.
Published: (2015)

Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose
by: Adewumi, A., et al.
Published: (2018)

Prescribing opioid analgesics for chronic non-malignant pain in general practice - a survey of attitudes and practice
by: Blake, Holly, et al.
Published: (2015)

The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia
by: Roxburgh, A., et al.
Published: (2023)

Is maternal therapeutic opioid use instigating misdiagnosis in breastfed infants? A case report
by: Ahmadzai, Hilai, et al.
Published: (2020)

The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs
by: Horyniak, Danielle, et al.
Published: (2013)

Prevalence and associated factors of opioid relapse among methadone maintenance therapy patients in Johor Bahru government health clinics, Malaysia
by: Mohmad, Faradia
Published: (2021)

Design, synthesis and pharmacological evaluation of novel fluorescent ligands for the mu-opioid receptor
by: Marshall, William
Published: (2021)

Postoperative pain assessment, and opioid utilisation after hospital discharge following colectomy
by: Baamer, Reham
Published: (2024)

Assessing causality in drug policy analyses: How useful are the Bradford Hill criteria in analysing take-home naloxone programs?
by: Olsen, A., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c4nao3p46fm2nqls3icdslljjt